Distinct DNA Methylation Profiles in Ovarian Tumors: Opportunities for Novel Biomarkers

Distinct DNA Methylation Profiles in Ovarian Tumors: Opportunities for Novel Biomarkers

Aberrant methylation of multiple promoter CpG islands could be related to the biology of ovarian tumors and its determination could help to improve treatment strategies. DNA methylation profiling was performed using the Methylation Ligation-dependent Macroarray (MLM), an array-based analysis. Promot...

Full description

Bibliographic Details
Main Authors:	Lorena Losi, Sergio Fonda, Sara Saponaro, Sonia T. Chelbi, Cesare Lancellotti, Gaia Gozzi, Loredana Alberti, Luca Fabbiani, Laura Botticelli, Jean Benhattar
Format:	Article
Language:	English
Published:	MDPI AG 2018-05-01
Series:	International Journal of Molecular Sciences
Subjects:	ovarian carcinoma DNA methylation profiling Wnt pathway DNA damage repair system TERT MGMT BRCA1 MLH1 OSMR ESR1 FOXL2
Online Access:	http://www.mdpi.com/1422-0067/19/6/1559

Similar Items

Investigation of MLH1, MGMT, CDKN2A, and RASSF1A Gene Methylation in Thymomas From Patients With Myasthenia Gravis
by: Fabio Coppedè, et al.
Published: (2020-10-01)

Correlation of chromosome damage and promoter methylation status of the DNA repair genes MGMT and hMLH1 in Chinese vinyl chloride monomer (VCM)-exposed workers
by: Fen Wu, et al.
Published: (2013-02-01)

Aberrantly Methylated MGMT, hMLH1 and hMSH2 in Tumor and Serum DNA of Gliomas Patients
by: Chanqing ZHENG, et al.
Published: (2009-02-01)

Expression of MGMT, hMLH1 and XRCC1 in Gastric Cancer Tissue and Their Clinical Significance
by: Xiao-feng LI, et al.
Published: (2015-03-01)

DNA Methylation by Bisulfite Next-Generation Sequencing for MLH1 and MGMT in Oral Squamous Cell Carcinomas and Potentially Malignant Disorders: An Integrative Analysis towards Field Cancerization
by: Blanco-Carrión, A., et al.
Published: (2022)

Genetic and epigenetic characteristics in ovarian tissues from polycystic ovary syndrome patients with irregular menstruation resemble those of ovarian cancer
by: Jiao Jiao, et al.
Published: (2019-03-01)

Constitutional Mosaic Epimutations – a hidden cause of cancer?
by: Per E. Lønning, et al.
Published: (2019-03-01)

Vitamin E Modifies High-Fat Diet-Induced Increase of DNA Strand Breaks, and Changes in Expression and DNA Methylation of Dnmt1 and MLH1 in C57BL/6J Male Mice
by: Marlene Remely, et al.
Published: (2017-06-01)

Methylation of BRCA1 and MGMT genes in white blood cells are transmitted from mothers to daughters
by: Nisreen Al-Moghrabi, et al.
Published: (2018-07-01)

Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation
by: Cheila Brito, et al.
Published: (2019-10-01)

Involvement of epigenetic modification of TERT promoter in response to all-trans retinoic acid in ovarian cancer cell lines
by: Lorena Losi, et al.
Published: (2019-07-01)

BRCA1 in the DNA damage response and at telomeres
by: Eliot Michael Rosen
Published: (2013-06-01)

Next-Generation Sequencing Analysis of ctDNA for the Detection of Glioma and Metastatic Brain Tumors in Adults
by: Jianfeng Liang, et al.
Published: (2020-08-01)

Mammographic Density and Estrogen Receptor α Gene Polymorphism in Javanese Women
by: Lina Choridah, et al.
Published: (2017-06-01)

Characteristic promoter hypermethylation signatures in male germ cell tumors
by: Bosl George J, et al.
Published: (2002-11-01)

FOXL2 and DMRT1L Are Yin and Yang Genes for Determining Timing of Sex Differentiation in the Bivalve Mollusk Patinopecten yessoensis
by: Ruojiao Li, et al.
Published: (2018-08-01)

FROM FAMILIES SYNDROMES TO GENES… THE FIRST CLINICAL AND GENETIC CHARACTERIZATIONS OF HEREDITARY SYNDROMES PREDISPOSING TO CANCER: WHAT WAS THE BEGINNING?
by: Charité Ricker, MS, LCGC
Published: (2017-07-01)

A type I combi-targeting approach for the design of molecules with enhanced potency against BRCA1/2 mutant- and O6-methylguanine-DNA methyltransferase (mgmt)- expressing tumour cells
by: Zhor Senhaji Mouhri, et al.
Published: (2017-08-01)

Selected aspects of inherited susceptibility to prostate cancer and tumours of different site of origin
by: Cybulski Cezary
Published: (2007-09-01)

The role of the oncostatin M/OSM receptor β axis in activating dermal microvascular endothelial cells in systemic sclerosis
by: G. Marden, et al.
Published: (2020-07-01)

Vitamin and antioxidant rich diet increases <it>MLH1</it> promoter DNA methylation in DMT2 subjects
by: Switzeny Olivier J, et al.
Published: (2012-10-01)

An evolutionary explanation for antibiotics' association with increased colon cancer risk
by: Voskarides, K.
Published: (2022)

Isocitrate dehydrogenase 1 and 2 genes mutations and MGMT methylation in gliomas
by: D. V. Tabakov, et al.
Published: (2017-04-01)

MicroRNAs down-regulate homologous recombination in the G1 phase of cycling cells to maintain genomic stability
by: Young Eun Choi, et al.
Published: (2014-04-01)

Radiosensitizing activity of novel small molecule BRCA1 and DNA-PK inhibitors in lung and colon carcinoma
by: Suraj Radhamani, Ph.D, et al.
Published: (2017-07-01)

The interaction between TERT promoter mutation and MGMT promoter methylation on overall survival of glioma patients: a meta-analysis
by: Huy Gia Vuong, et al.
Published: (2020-09-01)

Functional Analysis of BARD1 and BRCA1 Variants of Uncertain Significance in Homology-Directed Repair
by: Adamovich, Aleksandra Igorevna
Published: (2019)

Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer
by: Lorenzo Gerratana, et al.
Published: (2020-09-01)

Identification Of Novel MLH 1p Interacting Proteins By Biochemical And Genetic Methods
by: Kumaran, M
Published: (2011)

Implication de la mutation C134W de la protéine FOXL2 dans les tumeurs du stroma et des cordons sexuels de l'ovaire
by: Goulvent, Thibaut
Published: (2014)

Cáncer hereditario: fundamentos genéticos
by: Trinidad Caldés
Published: (2005-01-01)

MLH1 enhances the sensitivity of human endometrial carcinoma cells to cisplatin by activating the MLH1/c-Abl apoptosis signaling pathway
by: Yue Li, et al.
Published: (2018-12-01)

Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review
by: Takanori Yokoyama, et al.
Published: (2018-05-01)

ESR1 Gene Mutation in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer Patients: Concordance Between Tumor Tissue and Circulating Tumor DNA Analysis
by: Loredana Urso, et al.
Published: (2021-03-01)

Chlorambucil targets BRCA1/2‐deficient tumours and counteracts PARP inhibitor resistance
by: Eliana MC Tacconi, et al.
Published: (2019-07-01)

Graphene-Coated Optical Fiber SPR Biosensor for BRCA1 and BRCA2 Breast Cancer Biomarker Detection: a Numerical Design-Based Analysis
by: Md. Biplob Hossain, et al.
Published: (2019-05-01)

BRCA1 and BRCA2 Genetic Testing in Breast and/or Ovarian Cancer Families in Iran
by: Fatemeh Keshavarzi, et al.
Published: (2010-01-01)

Clinical use and mechanisms of resistance for PARP inhibitors in homologous recombination-deficient cancers
by: Dawn C. Janysek, et al.
Published: (2021-03-01)

Egr-1 regulates the transcription of the BRCA1 gene by etoposide
by: Soon Young Shin, et al.
Published: (2013-02-01)

Elucidating the molecular network underlying temperature-dependent sex determination in the red-eared slider turtle, Trachemys scripta
by: Shoemaker, Christina May
Published: (2012)

Cannot write session to /tmp/vufind_sessions/sess_4e2silamer3f3v9kg9enm9nq3n